McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 15, 2020
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Stock Option (right to buy)
2020-12-11+120,000→ 120,000 totalExercise: $4.32Exp: 2030-12-11→ Common Stock (120,000 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted as part of the Issuer's annual compensation review to executive officers.